Foghorn Therapeutics Inc. (FHTX) vs LENZ Therapeutics, Inc. (LENZ)

A side-by-side comparison of Foghorn Therapeutics Inc. and LENZ Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — FHTX vs LENZ

growth of $100 · dividends reinvested · last 5y
FHTX -80.6% (-27.9%/yr)LENZ -91.4% (-38.7%/yr)FHTX compounded faster over this window
050100150200Start $10020222023202420252026$19$9
FHTX LENZ

FHTX vs LENZ: by the numbers

  • •LENZ is the larger company ($119M vs $113M market cap).
  • •Both run net losses; FHTX's is the smaller (-175.78% vs -586.74% net margin).

Metrics side by side

Valuation

MetricFHTXLENZ
P/S ratio3.085.53
P/B ratioN/A0.54

Profitability

MetricFHTXLENZ
Gross margin89.22%90.14%
Operating margin-265.64%-477.46%
Net margin-175.78%-586.74%
ROEN/A-57.47%
ROIC-44.81%-61.84%

Growth (annualized)

MetricFHTXLENZ
Revenue CAGR (5Y)105.83%N/A
Total return CAGR (5Y)-31.87%-35.49%

Frequently asked

How have FHTX and LENZ total returns compared?
Over the past 5 years, FHTX delivered -31.87% and LENZ delivered -35.49% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.